SARS-COV-2 variants: differences and potential of immune evasion


Butantan affiliation
Publication type
Article
Language
English
Access rights
Open access
Terms of use
CC BY
Appears in Collections:
Metrics
Abstract
The structural spike (S) glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) plays an essential role in infection and is an important target for neutralizing antibody recognition. Mutations in the S gene can generate variants of concern (VOCs), which improve “viral fitness” through selective or survival advantages, such as increased ACE-2 receptor affinity, infectivity, viral replication, higher transmissibility, resistance to neutralizing antibodies and immune escape, increasing disease severity and reinfection risk. Five VOCs have been recognized and include B.1.1.7 (U.K.), B.1.351 (South Africa), P.1 (Brazil), B.1.617.2 (India), and B.1.1.529 (multiple countries). In this review, we addressed the following critical points concerning VOCs: a) characteristics of the SARS-CoV-2 VOCs with mutations in the S gene; b) possible evasion of variants from neutralizing antibodies generated through vaccination, previous infection, or immune therapies; c) potential risk of new pandemic waves induced by the variants worldwide; and d) perspectives for further studies and actions aimed at preventing or reducing the impact of new variants during the current COVID-19 pandemic.
Reference
Hirabara SM., Serdan TD.A., Gorjao R, Masi LN., Pithon-Curi TC., Covas DT, et al. SARS-COV-2 variants: differences and potential of immune evasion. Front. Cell. Infect. Microbiol. 2022 Jan;11:781429. doi:10.3389/fcimb.2021.781429.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/4147
URL
https://doi.org/10.3389/fcimb.2021.781429
Issue Date
2022


Files in This Item:

1-s2.0-S1874391922000203-main (1).pdf
Description:
Size: 5.48 MB
Format: Adobe PDF
View/Open
Show full item record

This item is licensed under a Creative Commons License Creative Commons